Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Challenges and solutions in patient treatment strategies for stage II colon cancer.

Fotheringham S, Mozolowski GA, Murray EMA, Kerr DJ.

Gastroenterol Rep (Oxf). 2019 Jun;7(3):151-161. doi: 10.1093/gastro/goz006. Epub 2019 Mar 11. Review.

2.
3.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
4.

Adjuvant therapy for colon cancer.

Sun W, Haller DG.

Curr Oncol Rep. 2005 May;7(3):181-5. Review.

PMID:
15847708
5.

Challenges in the management of stage II colon cancer.

Dotan E, Cohen SJ.

Semin Oncol. 2011 Aug;38(4):511-20. doi: 10.1053/j.seminoncol.2011.05.005. Review.

6.

Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients.

Dienstmann R, Salazar R, Tabernero J.

J Clin Oncol. 2015 Jun 1;33(16):1787-96. doi: 10.1200/JCO.2014.60.0213. Epub 2015 Apr 27. Review.

PMID:
25918287
7.

Current status of gene expression profiling to assist decision making in stage II colon cancer.

Chee CE, Meropol NJ.

Oncologist. 2014 Jul;19(7):704-11. doi: 10.1634/theoncologist.2013-0471. Epub 2014 May 28.

8.

Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer.

Wong AC, Stock S, Schrag D, Kahn KL, Salz T, Charlton ME, Rogers SO Jr, Goodman KA, Keating NL.

J Oncol Pract. 2014 Sep;10(5):e360-7. doi: 10.1200/JOP.2013.001309. Epub 2014 Jul 1.

9.

Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Lin CC, Lin JK, Chang SC, Wang HS, Yang SH, Jiang JK, Chen WS, Lin TC.

Int J Colorectal Dis. 2009 Jun;24(6):665-76. doi: 10.1007/s00384-009-0634-1. Epub 2009 Feb 24.

PMID:
19238405
10.

Recent approaches to identifying biomarkers for high-risk stage II colon cancer.

Akiyoshi T, Kobunai T, Watanabe T.

Surg Today. 2012 Nov;42(11):1037-45. doi: 10.1007/s00595-012-0324-4. Epub 2012 Sep 9. Review.

PMID:
22961195
11.

Prognostic and predictive significance of MSI in stages II/III colon cancer.

Saridaki Z, Souglakos J, Georgoulias V.

World J Gastroenterol. 2014 Jun 14;20(22):6809-14. doi: 10.3748/wjg.v20.i22.6809. Review.

12.

Adjuvant therapy for completely resected stage II colon cancer.

Figueredo A, Coombes ME, Mukherjee S.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005390. doi: 10.1002/14651858.CD005390.pub2. Review.

PMID:
18646127
13.

KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2010;10(25):1-49. Epub 2010 Dec 1.

14.

Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.

O'Connor ES, Greenblatt DY, LoConte NK, Gangnon RE, Liou JI, Heise CP, Smith MA.

J Clin Oncol. 2011 Sep 1;29(25):3381-8. doi: 10.1200/JCO.2010.34.3426. Epub 2011 Jul 25.

15.

Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy.

Auclin E, Zaanan A, Vernerey D, Douard R, Gallois C, Laurent-Puig P, Bonnetain F, Taieb J.

Ann Oncol. 2017 May 1;28(5):958-968. doi: 10.1093/annonc/mdx030. Review.

PMID:
28453690
16.

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.

Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, Wilcox-Fogel N, Forgó E, Rajendran PS, Miranda SP, Hisamori S, Hutchison J, Kalisky T, Qian D, Wolmark N, Fisher GA, van de Rijn M, Clarke MF.

N Engl J Med. 2016 Jan 21;374(3):211-22. doi: 10.1056/NEJMoa1506597.

17.

Chemotherapy for Stage II Colon Cancer.

Varghese A.

Clin Colon Rectal Surg. 2015 Dec;28(4):256-61. doi: 10.1055/s-0035-1564430. Review.

18.

Progress in systemic adjuvant therapy of early-stage breast cancer.

Gradishar WJ, O'Regan RM.

Int J Clin Oncol. 2003 Aug;8(4):239-47. Review.

PMID:
12955580
19.

Evolving role of gene expression signatures as biomarkers in early-stage colon cancer.

Goel G.

J Gastrointest Cancer. 2014 Dec;45(4):399-404. doi: 10.1007/s12029-014-9634-7. Review.

PMID:
24989938
20.

Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challenges.

Young PE, Womeldorph CM, Johnson EK, Maykel JA, Brucher B, Stojadinovic A, Avital I, Nissan A, Steele SR.

J Cancer. 2014 Mar 15;5(4):262-71. doi: 10.7150/jca.7988. eCollection 2014. Review.

Supplemental Content

Support Center